Home Article Combined therapy for COPD patients works, study says

Combined therapy for COPD patients works, study says

Combined therapy for COPD patients works, study says

Also Noted

Default Author Head Shot

By HME News Staff

Updated Tue September 6, 2016

LONDON - Adding home non-invasive ventilation to home oxygen therapy decreases the risk of re-hospitalization for COPD patients, according to a study presented this week at the 2016 European Respiratory Society International Congress. Patients in the study who received home non-invasive ventilation in addition to home oxygen therapy had a 51% decreased risk of re-hospitalization or death compared to those who received oxygen therapy alone. Patients who received home non-invasive ventilation went a median 4.3 months without dying or being admitted to the hospital, compared to 1.4 months for those who did not receive non-invasive ventilation, according to the study. Both ResMed and Philips Respironics participated in the multicenter, randomized controlled study, known as “Home Oxygen Therapy - Home Mechanical Ventilation” or HOT-HMV. In press releases, the companies pointed to the potential savings of combining home non-invasive ventilation and home oxygen therapy to care for patients with COPD, which costs the U.S. $36 billion in direct and indirect costs.

Comments

To comment on this post, please log in to your account or set up an account now.